Skip to content

Use of Indocyanine Green in Acute Cholecystitis

INDURG TRIAL: A Randomized Controlled Trial Using Indocyanine Green During Cholecystectomy in Acute Cholecystitis

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05709548
Acronym
INDURG
Enrollment
440
Registered
2023-02-02
Start date
2023-03-15
Completion date
2025-12-31
Last updated
2023-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Cholecystitis, Bile Duct Injury

Keywords

Indocyanine green

Brief summary

Laparoscopic cholecystectomy is one of the most common gastrointestinal surgeries. However, it can be technically complex in those patients diagnosed with acute cholecystitis who present severe inflammation or fibrosis, with bile duct injury being one of its main complications. The use of fluorescence cholangiography through the use of indocyanine green allows the identification of extrahepatic biliary structures, facilitating dissection and reducing the risk of bile duct lesions. Better visualization of the bile duct allows reducing the conversion rate to open surgery, as well as operating time. The main objective is to assess a decrease in operating time in acute cholecystitis undergoing emergency surgery, to which indocyanine green is administered preoperatively. Randomized, prospective, controlled, multicenter clinical trial of two groups of patients diagnosed with acute cholecystitis and requiring urgent cholecystectomy. The control group includes 220 patients who undergo urgent laparoscopic cholecystectomy according to the usual technique without the administration of indocyanine green, and the intervention group includes 220 patients who undergo urgent laparoscopic cholecystectomy for acute cholecystitis with the administration of indocyanine green preoperatively. Study led by the Parc Taulí University Hospital in Sabadell.

Detailed description

Prospective, controlled, randomized and multicenter clinical trial comparing conventional laparoscopic cholecystectomy versus laparoscopic cholecystectomy with preoperative indocyanine green administration in patients with an indication for urgent cholecystectomy due to acute cholecystitis (of any etiology), at the Parc Taulí University Hospital and at the Germans Trias i Pujol University Hospital. Parallel group randomization (1:1) will be performed by opening sealed envelopes, with random assignment between the two groups (intervention and control). The same number of envelopes will be assigned to the study and control group, all of them sealed and placed at random. A four-port laparoscopic cholecystectomy will be performed by a team of surgeons with extensive experience in emergency and/or hepatobiliopancreatic surgery, according to standard techniques and safety measures. Randomization will be carried out at the time of the indication for surgery, after acceptance and signing of the informed consent once all the inclusion criteria are met.

Interventions

DRUGIndocyanine green

Subjects with a diagnosis of acute cholecystitis who undergo urgent laparoscopic cholecystectomy with the preoperative administration of indocyanine green (between 1-2 hours prior to surgery).

Sponsors

Corporacion Parc Tauli
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Patients with an indication for urgent laparoscopic cholecystectomy due to acute cholecystitis regardless of its etiology. * Age over 18 years. * Patients who have read the study information sheet and signed the informed consent sheet.

Exclusion criteria

* Pregnant or breastfeeding patients. * Grade IV renal failure or patients on dialysis * Patients with previous hypersensitivity to indocyanine green * Patients with allergy to iodinated contrast * Patients with clinical hyperthyroidism, autonomic thyroid adenomas, and focal and diffuse autonomic abnormalities of the thyroid gland * Contraindication to laparoscopic surgery. * Suspicion of choledocholithiasis * Pediatric patients under 18 years of age. * Patients who refused to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
operating timefrom the beginning of the surgery to its end, up to 300 minutestime between the start of the surgical incision and the end of surgery

Secondary

MeasureTime frameDescription
admission dayslength of hospital stay, from admission to discharge, up to 3 monthdays of hospital admission
intraoperative complicationsduring surgical timesurgical injuries during surgery
postoperative morbidityin the first 30 days after surgerycomplications evidenced in the postoperative period
visualization of biliary anatomy with indocyanine greenduring surgical timeEvidence the correct visualization of the biliary structures after the administration of indocyanine green

Countries

Spain

Contacts

Primary ContactAnna Muñoz Campaña, PhD
amunozc@tauli.cat003493 723 10 10
Backup ContactColoma Moreno
cmoreno@tauli.cat003493 723 10 10

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026